+86-13708084407
  export@pu-kang.com            lorena@pu-kang.com
 
You are here: Home » News » 隐藏 » Three characteristics of the production of Semaglutide intermediates

Three characteristics of the production of Semaglutide intermediates

Views: 0     Author: Site Editor     Publish Time: 2021-09-22      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

The various products produced by Semaglutide are Semaglutide intermediates, and the synthesis of Semaglutide is strongly dependent on the intermediates. Lab synthesized long-acting semaglutide intermediates are important raw materials for the assembly of genus Apis and belong to the class of chemical merchandise. The assembly plant doesn't need GMP certification. And its production contains a sure degree of quality. In terms of website choice, layout coming up with, and plant style, it's necessary to strictly follow GMP-related needs. Different from the general chemical production process, the Semaglutide intermediates production process has the characteristics of miniaturization, single batch intermittent, and multi-functionality. Here are some answers.

Here is the content list:

Miniaturization

Single batch intermittent

Multifunctional

Miniaturization

The production of Semaglutide intermediates has the characteristics of miniaturization. The characteristics of miniaturization are that the reactor is small, the raw materials are few and the requirements are precise, especially the liquid materials that are added during the reaction process, which require a small amount and need to be controlled. For example, the common hydrogenation reaction process in the production of glycolysis customized medical-grade semaglutide intermediates is a small-scale batch reaction, which chiefly includes the feeding method, the replacement method, the reaction method, the pressure relief method when the reaction, and also the discharge method. Hydrogen, solid materials, and liquid materials are all hydrogenation reaction process materials. The final method is to initially add solid and liquid materials, so add H below an explicit pressure for reaction. The addition of liquid materials is controlled, which is additionally a fine chemical action.

Single batch intermittent

The general chemical production method is generally continuous production. The difference is that the production process of Semaglutide intermediates is mostly single batch intermittent, usually frequent single batch production, which requires repeated pre-processing and post-processing, and these the process needs to meet the requirements of "Pharmaceutical Manufacturing Quality Management Practices". Within the continuous method, the raw materials endlessly submit to a collection of special instrumentation, every instrumentation is in steady-state operation and solely performs a particular process task, and also the product is output during a continuous flow mode. Intermittent production means the raw materials are processed by the required process sequence and operative conditions, and also the merchandise is output during a restricted quantity. The character of batch processes is dynamic, and operative conditions and merchandise quality can amendment over time.

Multifunctional

The reactor within the production of Semaglutide intermediates typically needs multi-step reactions or multiple processes, requiring {different| completely different|completely different} temperature management or pressure management at different stages. To finish the precise management of those processes, it's necessary to think about the characteristics of satisfying a good vary of changes once planning management schemes and instrument choice. The pharmaceutical business presently dominates the batch method exploitation batch reactors. The reactor with mischief-maker utilized in this methodology is appropriate for many of the unit operations of the pharmaceutical business, like reaction, extraction, distillation, and crystallization, etc. The planning of batch processes needs a lot of selections. The continual process methodology provides a lot of predictable zoom paths, additionally as some further operational benefits. These benefits build a lot of and a lot of pharmaceutical firms begin to use the continuous process as a brand new methodology to the particular production method of Api stable 98% semaglutide intermediates and active pharmaceutical ingredients.

If you are interested in pharmaceutical high purity powder semaglutide intermediates, you can contact us, our website is https://www.pu-kang.com/.


About Us
Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production.
Contact Us
​​​​​​​​​​​​​​No.288 of North Rongtai Avenue,WenJiang district 611137,Chengdu Sichuan
Province,China.
+86-28-63976226
Copyright © 2021 chengdu Pukang Biological Technology Co., Ltd.  Support By Leadong  Sitemap / Private Policy
Leave a Message
Contact us